BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 16598437)

  • 1. Antiangiogenic effect of 2-benzoyl-phenoxy acetamide in EAT cell is mediated by HIF-1alpha and down regulation of VEGF of in-vivo.
    Prabhakar BT; Khanum SA; Shashikanth S; Salimath BP
    Invest New Drugs; 2006 Nov; 24(6):471-8. PubMed ID: 16598437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiangiogenic and antiproliferative effects of substituted-1,3,4-oxadiazole derivatives is mediated by down regulation of VEGF and inhibition of translocation of HIF-1alpha in Ehrlich ascites tumor cells.
    Kumar A; D'Souza SS; Nagaraj SR; Gaonkar SL; Salimath BP; Rai KM
    Cancer Chemother Pharmacol; 2009 Nov; 64(6):1221-33. PubMed ID: 19370348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
    Chen MC; Lee CF; Huang WH; Chou TC
    Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiangiogenic effects of a novel synthetic curcumin analogue in pancreatic cancer.
    Nagaraju GP; Zhu S; Ko JE; Ashritha N; Kandimalla R; Snyder JP; Shoji M; El-Rayes BF
    Cancer Lett; 2015 Feb; 357(2):557-65. PubMed ID: 25497868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular and functional evaluation of a novel HIF inhibitor, benzopyranyl 1,2,3-triazole compound.
    Park K; Lee HE; Lee SH; Lee D; Lee T; Lee YM
    Oncotarget; 2017 Jan; 8(5):7801-7813. PubMed ID: 27999195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of indatraline on angiogenesis suppression through HIF-1α-mediated VEGF inhibition.
    Yen CN; Cho YS; Kwon HJ
    Biochem Biophys Res Commun; 2017 Apr; 485(2):349-354. PubMed ID: 28216154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiangiogenic effects of ganetespib in colorectal cancer mediated through inhibition of HIF-1α and STAT-3.
    Nagaraju GP; Park W; Wen J; Mahaseth H; Landry J; Farris AB; Willingham F; Sullivan PS; Proia DA; El-Hariry I; Taliaferro-Smith L; Diaz R; El-Rayes BF
    Angiogenesis; 2013 Oct; 16(4):903-17. PubMed ID: 23838996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A tumoural angiogenic gateway blocker, Benzophenone-1B represses the HIF-1α nuclear translocation and its target gene activation against neoplastic progression.
    Thirusangu P; Vigneshwaran V; Ranganatha VL; Vijay Avin BR; Khanum SA; Mahmood R; Jayashree K; Prabhakar BT
    Biochem Pharmacol; 2017 Feb; 125():26-40. PubMed ID: 27838496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel antiangiogenic anticancer activities of deguelin targeting hypoxia-inducible factor-1 alpha.
    Oh SH; Woo JK; Jin Q; Kang HJ; Jeong JW; Kim KW; Hong WK; Lee HY
    Int J Cancer; 2008 Jan; 122(1):5-14. PubMed ID: 17764071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of HIF-1alpha activity by BP-1 ameliorates adjuvant induced arthritis in rats.
    Shankar J; Thippegowda PB; Kanum SA
    Biochem Biophys Res Commun; 2009 Sep; 387(2):223-8. PubMed ID: 19664474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BP-1T, an antiangiogenic benzophenone-thiazole pharmacophore, counteracts HIF-1 signalling through p53/MDM2-mediated HIF-1α proteasomal degradation.
    Thirusangu P; Vigneshwaran V; Prashanth T; Vijay Avin BR; Malojirao VH; Rakesh H; Khanum SA; Mahmood R; Prabhakar BT
    Angiogenesis; 2017 Feb; 20(1):55-71. PubMed ID: 27743086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Butyrate-induced proapoptotic and antiangiogenic pathways in EAT cells require activation of CAD and downregulation of VEGF.
    Belakavadi M; Prabhakar BT; Salimath BP
    Biochem Biophys Res Commun; 2005 Oct; 335(4):993-1001. PubMed ID: 16105646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apigenin inhibits tumor angiogenesis through decreasing HIF-1alpha and VEGF expression.
    Fang J; Zhou Q; Liu LZ; Xia C; Hu X; Shi X; Jiang BH
    Carcinogenesis; 2007 Apr; 28(4):858-64. PubMed ID: 17071632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, angiopreventive activity, and in vivo tumor inhibition of novel benzophenone-benzimidazole analogs.
    Ranganatha VL; Vijay Avin BR; Thirusangu P; Prashanth T; Prabhakar BT; Khanum SA
    Life Sci; 2013 Nov; 93(23):904-11. PubMed ID: 24135459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combinatorial antitumor effect of naringenin and curcumin elicit angioinhibitory activities in vivo.
    Anand K; Sarkar A; Kumar A; Ambasta RK; Kumar P
    Nutr Cancer; 2012; 64(5):714-24. PubMed ID: 22642894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Ehrlich ascites cancer, hypoxia-inducible factor-1 alpha, and the kinase insert domain-containing receptor/
    Madhu LN; Telkar S; Kamath D; D Souza ME; Rao S; Nayak PS; Sarojini BK
    J Cancer Res Ther; 2020 Dec; 16(Supplement):S74-S81. PubMed ID: 33380656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudolaric acid B inhibits angiogenesis and reduces hypoxia-inducible factor 1alpha by promoting proteasome-mediated degradation.
    Li MH; Miao ZH; Tan WF; Yue JM; Zhang C; Lin LP; Zhang XW; Ding J
    Clin Cancer Res; 2004 Dec; 10(24):8266-74. PubMed ID: 15623602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of hypoxia inducible factor-1alpha by dihydroxyphenylethanol, a product from olive oil, blocks microsomal prostaglandin-E synthase-1/vascular endothelial growth factor expression and reduces tumor angiogenesis.
    Terzuoli E; Donnini S; Giachetti A; Iñiguez MA; Fresno M; Melillo G; Ziche M
    Clin Cancer Res; 2010 Aug; 16(16):4207-16. PubMed ID: 20682710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of tumor angiogenesis by metformin treatment via a mechanism linked to targeting of HER2/HIF-1α/VEGF secretion axis.
    Wang J; Li G; Wang Y; Tang S; Sun X; Feng X; Li Y; Bao G; Li P; Mao X; Wang M; Liu P
    Oncotarget; 2015 Dec; 6(42):44579-92. PubMed ID: 26625311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiangiogenic activity of genistein in pancreatic carcinoma cells is mediated by the inhibition of hypoxia-inducible factor-1 and the down-regulation of VEGF gene expression.
    Büchler P; Reber HA; Büchler MW; Friess H; Lavey RS; Hines OJ
    Cancer; 2004 Jan; 100(1):201-10. PubMed ID: 14692041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.